Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.130
+0.290 (7.55%)
At close: Jun 26, 2026, 4:00 PM EDT
4.040
-0.090 (-2.18%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Ironwood Pharmaceuticals Employees
Ironwood Pharmaceuticals had 100 employees as of December 31, 2025. The number of employees decreased by 153 or -60.47% compared to the previous year.
Employees
100
Change (1Y)
-153
Growth (1Y)
-60.47%
Revenue / Employee
$3,615,140
Profits / Employee
$1,021,760
Market Cap
679.85M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,526 |
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Emergent BioSolutions | 900 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Evolus | 350 |
| Esperion Therapeutics | 294 |
IRWD News
- 23 days ago - Ironwood Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference - Business Wire
- 4 weeks ago - Ironwood says FDA approves use of Linzess in pediatric patients two and older - TheFly
- 4 weeks ago - FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC) - Business Wire
- 7 weeks ago - Ironwood Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - Ironwood Pharmaceuticals Earnings release: Q1 2026 - Filings
- 7 weeks ago - Ironwood Pharmaceuticals Slides: Q1 2026 - Filings
- 7 weeks ago - Ironwood Pharmaceuticals Quarterly report: Q1 2026 - Filings